Evaluation of amotosalen and UVA pathogen‐reduced apheresis platelets after 7‐day storage

BACKGROUND: Amotosalen/UVA pathogen‐reduced platelet components (PRPCs) with storage up to 7 days are standard of care in France, Switzerland, and Austria. PRPCs provide effective hemostasis with reduced risk of transfusion‐transmitted infections and transfusion‐associated graft versus host disease,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cancelas, Jose A., Genthe, Jamie R., Stolla, Moritz, Rugg, Neeta, Bailey, S. Lawrence, Nestheide, Shawnagay, Shaz, Beth, Mack, Samantha, Schroeder, Kadi, Anani, Waseem, Szczepiorkowski, Zbigniew M., Dumont, Larry J., Yegneswaran, Subramanian, Corash, Laurence, Mufti, Nina, Benjamin, Richard J., Erickson, Anna C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Blood Components
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546462/
https://www.ncbi.nlm.nih.gov/pubmed/35808974
http://dx.doi.org/10.1111/trf.17003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546462/
https://www.ncbi.nlm.nih.gov/pubmed/35808974
http://dx.doi.org/10.1111/trf.17003

Ejemplares similares